# Cardinal Health 414 LLC – FDA Inspection, Jan 23, 2026

Source: https://www.keypedia.com/records/fda_inspections/cardinal-health-414-llc/7fe99422-13a4-4a43-bd4d-353088a63181
Source feed: FDA_Inspections

> FDA inspection 1300324 of Cardinal Health 414 LLC, January 23, 2026. 2 citations under 21 CFR part 212. Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1300324
- Company Name: Cardinal Health 414 LLC
- Inspection Date: 2026-01-23
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Denver District Office
- Citation Count: 2

## Related Documents

- [FDA Inspection 1044553 - 2018-03-16](https://www.keypedia.com/records/fda_inspections/cardinal-health-414-llc/3f964fbe-22e8-4ecf-9c29-8d5fd7b437f9)
- [FDA Inspection 945255 - 2015-10-16](https://www.keypedia.com/records/fda_inspections/cardinal-health-414-llc/60243d03-88f3-4db0-871f-3a7243d78168)
- FDA Inspection 831436 - 2013-05-01
- FDA Inspection 710966 - 2011-01-13

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/christopher-r-czajka/42defbf3-ea06-4090-8d51-7da2b07d9e84)

Company: https://www.keypedia.com/companies/cardinal-health-414-llc/9ba62f77-6300-4af0-ac3d-b6f9f782038b

Office: https://www.keypedia.com/offices/denver-district-office/93b79063-390c-4759-af6c-5da7e388face